ASSEMBLY, LOCALIZATION AND FUNCTION OF THE U3 SNRNP

U3 SNRNP 的组装、定位和功能

基本信息

  • 批准号:
    2872695
  • 负责人:
  • 金额:
    $ 8.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-02-01 至 2001-01-31
  • 项目状态:
    已结题

项目摘要

The long term objective of our research is to understand the molecular events that occur in pre-ribosomal RNA (rRNA) processing in eukaryotes, focusing particularly of the role of the U3 small nuclear ribonucleoprotein (snRNP) in the initial pre-rRNA cleavage event. The U3 snRNP, one of the abundant snRNPs, has been shown to be essential for the first cleavage event in pre-rRNA processing in multiple organisms, from humans to yeast. In vertebrates, the U3 snRNP consists of an RNA about 200 nucleotides in length bound to several proteins. Although the U3 snRNP has been studied in a wide variety of species and cell types, both in vivo and in vitro, the molecular mechanism underlying its role in pre-rRNA processing remains largely unknown. In particular, it is not clear which of the protein components are critical for its activity or how they contribute to U3 snRNP biogenesis. Fibrillarin, one of the U3 proteins common to other nucleolar snRNPs, is a frequent target of the autoimmune response in patients with systemic sclerosis. Fibrillarin is the only U3 protein that has been previously studied in detail. The role(s) of the remaining five or more proteins in snRNP biogenesis and pre-rRNA processing remain to be elucidated. Five specific aims are proposed to pursue the nature of the assembly, biogenesis and function of the U3 snRNP: 1. Purify the U3 snRNP and its individual protein components from a mammalian source. 2. Clone the genes encoding the U3 proteins using the polymerase chain reaction. 3. Express the U3 proteins in E.coli and use the fusion proteins to derive specific antibodies. 4. Use the clones and antibodies to: a. Study the organization of the U3 proteins on the snRNA, b.Study the cellular biogenesis of the U3 snRNP, including proteins and RNA sequences necessary for nucleolar localization 5. Investigate the U3 snRNP components essential for pre-rRNA processing using an in vitro processing system.
我们研究的长期目标是了解分子

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan J Baserga其他文献

Susan J Baserga的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan J Baserga', 18)}}的其他基金

Predoctoral Program in Cellular, Molecular and Quantitative Biology (CMQBTP)
细胞、分子和定量生物学博士前课程 (CMQBTP)
  • 批准号:
    10628127
  • 财政年份:
    2023
  • 资助金额:
    $ 8.3万
  • 项目类别:
Novel regulatory networks driving human ribosome biogenesis
驱动人类核糖体生物发生的新型调控网络
  • 批准号:
    10370363
  • 财政年份:
    2019
  • 资助金额:
    $ 8.3万
  • 项目类别:
Novel regulatory networks driving human ribosome biogenesis
驱动人类核糖体生物发生的新型调控网络
  • 批准号:
    10786346
  • 财政年份:
    2019
  • 资助金额:
    $ 8.3万
  • 项目类别:
Novel regulatory networks driving human ribosome biogenesis
驱动人类核糖体生物发生的新型调控网络
  • 批准号:
    9900834
  • 财政年份:
    2019
  • 资助金额:
    $ 8.3万
  • 项目类别:
Novel regulatory networks driving human ribosome biogenesis
驱动人类核糖体生物发生的新型调控网络
  • 批准号:
    10582569
  • 财政年份:
    2019
  • 资助金额:
    $ 8.3万
  • 项目类别:
Key factors in human ribosome biogenesis
人类核糖体生物发生的关键因素
  • 批准号:
    9281554
  • 财政年份:
    2015
  • 资助金额:
    $ 8.3万
  • 项目类别:
Key factors in human ribosome biogenesis
人类核糖体生物发生的关键因素
  • 批准号:
    8943058
  • 财政年份:
    2015
  • 资助金额:
    $ 8.3万
  • 项目类别:
Assembly Localiztion and Function of the U3 snRNP
U3 snRNP 的组装定位和功能
  • 批准号:
    7883898
  • 财政年份:
    2009
  • 资助金额:
    $ 8.3万
  • 项目类别:
ASSEMBLY, LOCALIZATION AND FUNCTION OF THE U3 SNRNP
U3 SNRNP 的组装、定位和功能
  • 批准号:
    6151063
  • 财政年份:
    1996
  • 资助金额:
    $ 8.3万
  • 项目类别:
The Architecture and Function of RNPs Required for Ribosome Biogenesis
核糖体生物发生所需的 RNP 的结构和功能
  • 批准号:
    8215672
  • 财政年份:
    1996
  • 资助金额:
    $ 8.3万
  • 项目类别:

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
  • 批准号:
    EP/Y024540/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
  • 批准号:
    MR/Y008847/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
  • 批准号:
    BB/Y002180/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
  • 批准号:
    MR/Y003616/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
  • 批准号:
    MR/Y033698/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
  • 批准号:
    23H03716
  • 财政年份:
    2023
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
  • 批准号:
    23K06940
  • 财政年份:
    2023
  • 资助金额:
    $ 8.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了